Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2021 | $83,700 | | tax credit/rebate |
Jazz Pharmaceuticals Inc | Jazz Pharmaceuticals | Pennsylvania | state | 2021 | $80,200 | | tax credit/rebate |
Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical | Pennsylvania | state | 2021 | $53,100 | | tax credit/rebate |
Avid Radiopharmaceuticals Inc | Eli Lilly | Pennsylvania | state | 2021 | $28,300 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Pennsylvania | state | 2021 | $27,100 | | tax credit/rebate |
Glaxosmithkline Consumer Healthcare Hold | GlaxoSmithKline | Pennsylvania | state | 2021 | $15,900 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2021 | $196,021 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2021 | $3,478 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2021 | $6,048 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2021 | $23,132 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2021 | $13,628 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2021 | $27,752 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2021 | $20,214 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2021 | $72,208 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2021 | $512,192 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2021 | $13,776 | | tax credit/rebate |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2021 | $603,200 | | training reimbursement |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | | training reimbursement |
Genentech USA Inc | Roche | California | state | 2021 | $68,185 | | training reimbursement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Abiomed Inc. | Johnson & Johnson | Massachusetts | state | 2021 | $675,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2021 | $1,950,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2021 | $1,725,000 | | tax credit/rebate |
L. Perrigo Company | Perrigo | Michigan | local | 2021 | undisclosed | | property tax abatement |
Intervet Inc. | Merck | Kansas | state | 2022 | undisclosed | | tax credit/rebate |
Safc Biosciences | Merck KGaA (EMD) | Kansas | state | 2022 | undisclosed | | tax credit/rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | | tax rebate |
Astrazeneca Pharmaceuticals, Lp | AstraZeneca | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Gilead Sciences, Inc. & Subsidiaries | Gilead Sciences | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Emergent Biosolutions Inc. And Subsidiaries | Emergent BioSolutions | Maryland | state | 2022 | $130,702 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2022 | $34,500 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2022 | $21,412 | | tax credit/rebate |
Janssen Research & Development | Johnson & Johnson | Maryland | state | 2022 | $19,167 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
St. Jude Medical | Abbott Laboratories | Minnesota | state | 2022 | undisclosed | | sales tax exemption |
Regeneron Pharmaceuticals, Inc. (MH#2) | Regeneron Pharmaceuticals | New York | state | 2022 | $5,000,000 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. (MH#3) | Regeneron Pharmaceuticals | New York | state | 2022 | $2,500,000 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Ohio | state | 2022 | $2,080,000 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Eli Lilly and Company II | Eli Lilly | North Carolina | state | 2022 | $16,169,000 | | grant |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2022 | $200,152 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2022 | $12,182 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2022 | $4,871 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $47,494 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2022 | $18,821 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2022 | $19,911 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2022 | $53,699 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $14,958 | | training reimbursement |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Novartis Gene Therapies (frmly AveXis, Inc.) | Novartis | North Carolina | state | 2022 | $5,798 | | training reimbursement |
Pfizer (project 2) | Pfizer | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Pfizer, Inc. (Chapel Hill) | Pfizer | North Carolina | state | 2022 | $20,984 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2022 | $198,000 | | training reimbursement |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
Novo Nordisk US Bio Production Inc | Novo Holdings A/S | New Hampshire | state | 2022 | undisclosed | | tax credit/rebate |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Novo Nordisk Research Center Seattle, Inc. | Novo Holdings A/S | Washington | state | 2022 | $2,645,382 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Indiana | state | 2022 | $293,100,000 | | MEGADEAL |
Bristol Myers Squibb Company | Bristol-Myers Squibb | Arizona | state | 2022 | $3,000,000 | | tax credit/rebate |
Regeneron Building D | Regeneron Pharmaceuticals | New York | local | 2022 | $2,171,758 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2022 | $226,608 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2022 | $169,333 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2022 | $133,565 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $113,118 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Regeneron Phase II (aka LOOP Road project) | Regeneron Pharmaceuticals | New York | local | 2022 | $74,201 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $63,375 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2022 | $24,434 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2022 | $22,434 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | Virginia | state | 2023 | $300,000 | | grant |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2023 | $475,775 | | tax rebate |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |